Janson C - Search Results

1

What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape.

Lavorini F, Janson C, Braido F, Stratelis G, Løkke A. Lavorini F, et al. Among authors: janson c. Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619884532. doi: 10.1177/1753466619884532. Ther Adv Respir Dis. 2019. PMID: 31805823 Free PMC article. Review.

2

Plasma levels and effects of salbutamol after inhaled or i.v. administration in stable asthma.

Janson C. Janson C. Eur Respir J. 1991 May;4(5):544-50. Eur Respir J. 1991. PMID: 1936226

3

Phenotypes of obstructive lung disease.

Janson C. Janson C. Clin Respir J. 2008 Oct;2 Suppl 1:88-91. doi: 10.1111/j.1752-699X.2008.00090.x. Clin Respir J. 2008. PMID: 20298356 Review.

4

Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.

Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G. Larsson K, et al. Among authors: janson c. J Intern Med. 2013 Jun;273(6):584-94. doi: 10.1111/joim.12067. Epub 2013 Apr 1. J Intern Med. 2013. PMID: 23495860 Free article.

5

Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS).

Janson C, Larsson K, Lisspers KH, Ställberg B, Stratelis G, Goike H, Jörgensen L, Johansson G. Janson C, et al. BMJ. 2013 May 29;346:f3306. doi: 10.1136/bmj.f3306. BMJ. 2013. PMID: 23719639 Free PMC article. Clinical Trial.

6

Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS).

Ställberg B, Janson C, Johansson G, Larsson K, Stratelis G, Telg G, Lisspers KH. Ställberg B, et al. Among authors: janson c. Prim Care Respir J. 2014 Mar;23(1):38-45. doi: 10.4104/pcrj.2013.00106. Prim Care Respir J. 2014. PMID: 24346825 Free PMC article.

7

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.

Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED; Respiratory Effectiveness Group. Jones RC, et al. Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6. Epub 2014 Feb 13. Lancet Respir Med. 2014. PMID: 24717623 Free article.

8

Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.

Janson C, Lööf T, Telg G, Stratelis G, Nilsson F. Janson C, et al. NPJ Prim Care Respir Med. 2016 Nov 17;26:16053. doi: 10.1038/npjpcrm.2016.53. NPJ Prim Care Respir Med. 2016. PMID: 27853177 Free PMC article.

9

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.

Janson C, Stratelis G, Miller-Larsson A, Harrison TW, Larsson K. Janson C, et al. Int J Chron Obstruct Pulmon Dis. 2017 Oct 19;12:3055-3064. doi: 10.2147/COPD.S143656. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29089754 Free PMC article. Review.

10

Minimising the environmental impact of inhaled therapies.

Lehtimäki L, Björnsdóttir U, Janson C, Haahtela T. Lehtimäki L, et al. Among authors: janson c. Eur Respir J. 2020 May 27;55(5):2000721. doi: 10.1183/13993003.00721-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32461339 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

970 results

Search Page